Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1

Journal of Cellular Biochemistry

Volumn 110, Issue 2, 2010, Pages 382-391

  Blaukovitch, Cheryl Isleib ^a   Pugh, Raymond ^a   Gilotti, Albert C ^a   Kanyi, Daniela ^a   Lowe Krentz, Linda J ^a  

^a LEHIGH UNIVERSITY   (United States)

Author keywords

ERK; Heparin; MKP 1; Vascular smooth muscle

Indexed keywords

DOXORUBICIN; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SMALL INTERFERING RNA; VANADIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIBODIES; BLOTTING, WESTERN; CELLS, CULTURED; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; HEPARIN; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, CELL SURFACE; SWINE;

EID: 77952046530     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22543     Document Type: Article

References (49)

1. Begum N, Ragolia L, Rienzie J, McCarthy M, Duddy N. 1998. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. J Biol Chem 273:25164-25170.
2. Brondello J, Pouyssegur J, McKenzie FR. 1999. Reduced MAPK phosphatase- 1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286:2514-2517. (Pubitemid 30026341)
3. Brunet S, Roux D, Lenomand P, Dowd S, Keyse S, Pouysségur J. 1999. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674. (Pubitemid 29057251)
4. Castellot JJJ, Addonizio ML, Rosenberg R, Karnovsky MJ. 1981. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol 90:372-379.
5. Castellot JJJ, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ. 1985. Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol 124:13-20. (Pubitemid 15042633)
6. Caunt CJ, Rivers CA, Conway-Campbell BL, Norman MR, McArdle CA. 2008. Epidermal growth factor receptor and protein kinase C signaling to ERK2. Spatiotemporal regulation of ERK2 by dual specificity phosphatases. J Biol Chem 283:6241-6252.
7. Choi B-H, Hur E-M, Lee J-H, Jun D-J, Kim K-T. 2006. Protein kinase Cd-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. J Cell Sci 119:1329-1340. (Pubitemid 43756549)
8. Chua C, Rahimi N, Forsten-Williams K, Nugent MA. 2004. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2. Circ Res 94:316-323. (Pubitemid 38240722)
9. Dickinson R, Keyse S. 2006. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J Cell Sci 119:4607-4615. (Pubitemid 44964257)
10. Duff JL, Marrero MB, Paxton WG, Charles CH, Lau LF, Bernstein KE, Berk BC. 1993. Angiotensin II induces 3CH134, a protein tyrosine phosphatase, in vascular smooth muscle cells. J Biol Chem 268:26037-26040. (Pubitemid 23361658)
11. Duff JL, Monia BP, Berk BC. 1995. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J Biol Chem 270:7161-7166.
12. Eljaschewitch E, Witting A, Mawrin C, Lee T, Schmidt P, Wolf S, Hoertnagl H, Raine C, Schneider-Stock R, Nitsch R, Ullrich O. 2006. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49:67-79. (Pubitemid 43017186)
13. Fasciano S, Patel R, Handy I, Patel C. 2005. Regulation of vascular smooth muscle proliferation by heparin. Inhibition of cyclin-dependent kinase 2 activity by p27kip1. J Biol Chem 280:15682-15689. (Pubitemid 40616687)
14. Furst R, Brueckl C, Kuebler W, Zahler S, Krotz F, Gorlach A, Vollmar A, Kiemer A. 2005. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96:43-53. (Pubitemid 40095753)
15. Garrington TP, Johnson GL. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11:211-218. (Pubitemid 29164036)
16. Hamel M, Kanyi D, Cipolle MD, Lowe-Krentz LJ. 2006. Active stress kinases in proliferating endothelial cells associate with cytoskeletal structures. Endothelium 13:157-170. (Pubitemid 44110582)
17. Kim F, Corson MA. 2000. Adhesion to fibronectin enhances MKP-1 activation in human endothelial cells. Biochem Biophys Res Commun 273:539-545. (Pubitemid 30599021)
18. Kinney CM, Chandrasekharan U, Mavrakis L, DiCorleto PE. 2008. VEGF and thrombin induce MKP-1 through distinct signaling pathways: Role of MKP-1 in endothelial cell migration. Am J Physiol Cell Physiol 294:241-250.
19. Kinsella M, Wight T. 1986. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration. J Cell Biol 102:679-687. (Pubitemid 16013126)
20. Kondoh K, Nishida E. 2007. Regulation of MAP kinases by MAP kinase phosphatases. BBA Mol Cell Res 1773:1227-1237. (Pubitemid 47125976)
21. Kuwano Y, Kim H, Abdelmohsen K, Pullmann R, Martindale J, Yang X, Gorospe M. 2008. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol 28:4562-4575. (Pubitemid 351977754)
22. Lavoie J, L'Allemain G, Brunet A, Muller R, Pouyssegur J. 1996. Cyclin D1 expression is regulated positively by the p42/p44 MAPK and negatively by the p38/HOG MAPK pathway. J Biol Chem 271:20608-20616. (Pubitemid 26281839)
23. Lents N, Keenan S, Bellone C, Baldassare J. 2002. Stimulation of the Raf/ MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2. J Biol Chem 277:47469-47475. (Pubitemid 36159264)
24. Li M, Zhou J-Y, Ge Y, Matherly L, Wu G. 2003. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J Biol Chem 278:41059-41068. (Pubitemid 37280929)
25. Li L, Chen S-F, Liu Y. 2009. MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med 2:4867.
26. Skp2 for MKP-1 destruction provides a positive feedback regulation of proliferation signaling. J Biol Chem 281:915-926.
27. Lin Y, Chuang S, Yang J. 2003. ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J Biol Chem 278:21534-21541. (Pubitemid 36792551)
28. Marcum J, Atha D, Fritz L, Nawroth PP, Stern DM, Rosenberg R. 1986. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycans. J Biol Chem 261:7507-7517. (Pubitemid 17224759)
29. Metzler B, Hu Y, Strum G, Wick G, Xu Q. 1998. Induction of mitogen-activated protein kinase phosphatase-1 by arachidonic acid in vascular smooth muscle cells. J Biol Chem 273:33320-33326. (Pubitemid 29005708)
30. Ottlinger ME, Pukac LA, Karnovsky MJ. 1993. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem 268:19173-19176. (Pubitemid 23270681)
31. Pan M-R, Chang H-C, Hung W-C. 2008. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases. Cell Signal 20:1134-1141.
32. Patton WAI, Granzow CA, Getts LA, Thomas SC, Zotter LM, Gunzel KA, Lowe-Krentz LJ. 1995. Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. Biochem J 311:461-469.
33. Poizat C, Puri P, Bai Y, Kedes L. 2005. Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol 25:2673-2678. (Pubitemid 40381631)
34. Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ. 1997. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. J Cell Physiol 172:69-78. (Pubitemid 27283349)
35. 1 phase of the cell cycle. J Biol Chem 264:6990-6995.
36. Ross R. 1999. Atherosclerosis. An inflammatory disease. N Engl J Med 340: 115-126.
37. Ryser S, Massiha A, Piuz I, Schlegel W. 2004. Stimulated initiation of mitogen-activated protein kinase phosphatase-1 (MKP-1) gene transcription involves the synergistic action of multiple cis-acting elements in the proximal promoter. Biochem J 378:473-484. (Pubitemid 38367237)
38. Sakakibara K, Kubota K, Worku B, Ryer E, Miller J, Koff A, Kent C, Liu B. 2005. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem 280:25470-25477. (Pubitemid 40962251)
39. Savage JM, Gilotti AC, Granzow CA, Molina F, Lowe-Krentz LJ. 2001. Antibodies against a heparin receptor slow cell proliferation and decrease MAPK activation in vascular smooth muscle cells. J Cell Physiol 187:283-293. (Pubitemid 32378353)
40. Small G, Somasundaram S, Moore D, Shi Y, Orlowski R. 2003. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK. J Pharmacol Exp Ther 307:861-869. (Pubitemid 37494202)
41. Stork PJ. 2002. ERK signaling. Duration, duration, duration. Cell Cycle 5: 315-317.
42. Sun H, Charles CH, Lau LF, Tonks NK. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493. (Pubitemid 23335074)
43. Teng C-H, Huang W-N, Meng T-C. 2007. Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. J Biol Chem 282:28395-28407.
44. Vogt A, Tamewitz A, Skoko J, Sikorski R, Giuliano K, Lazo J. 2005. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 280:19078-19086. (Pubitemid 41379614)
45. Wayne J, Sielski J, Rizvi A, Georges K, Hutter D. 2006. ERK regulation upon contact inhibition in fibroblasts. Mol Cell Biochem 286:181-189.
46. Wong H, Dunsmore K, Page K, Shanley T. 2005. Heat shock-mediated regulation of MKP-1. Am J Physiol Cell Physiol 289:C1152-C1158.
47. Wu W, Pew T, Zou M, Pang D, Conzen SD. 2005. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxelassociated MAPK activation and contributes to breast cancer cell survival. J Biol Chem 280:4117-4124. (Pubitemid 40288576)
48. Wu JJ, Roth RJ, Anderson EJ, Hong E-G, Lee M-K, Choi CS, Neufer PD, Shulman GI, Kim JK, Bennett AM. 2006. Mice lacking MAP kinase phosphatase- 1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab 4:61-73.
49. Zheng Y, Im C-N, Seo J-S. 2006. Inhibitory effect of Hsp70 on angiotensin II-induced vascular smooth muscle cell hypertrophy. Exp Mol Med 38:509-518. (Pubitemid 44704049)